Delineation of clinical target volume in nasopharyngeal carcinoma
Quxia Zhang(Fujian Medical University), Shaojun Lin(Fujian Medical University)
Cited by 1
Related Papers
Nivolumab combined with induction chemotherapy and radiotherapy in nasopharyngeal carcinoma: A multicenter phase 2 PLATINUM trial
|Cancer Cell|2025|36
<p>Stanniocalcin 2 (STC2) expression promotes post-radiation survival, migration and invasion of nasopharyngeal carcinoma cells</p>
|Cancer Management and Research|2019|30
International Consensus Guideline on Delineation of the Clinical Target Volumes at Different Dose Levels for Nasopharyngeal Carcinoma (2024 Version)
|International Journal of Radiation Oncology*Biology*Physics|2025|12